Month: October 2022
-
Novel Treatment Effective for Bladder Cancer, Study Shows in Mice
An epigenetics drug currently being used for the treatment of blood cancers and rare sarcomas can stop the growth of bladder cancer by activating the immune system, according to a new study.
-
Investigating the Role of Fatty Acids in Cancer Cell Survival
Northwestern Medicine investigators have discovered that a particular enzyme is essential for regulating cancer cell survival and metastasis under cellular stress, according to a recent study.
-
Northwestern Investigates COVID-19: Sentinel Surveillance, ‘Long COVID’ in Children
Northwestern Medicine investigators continue to investigate the impact of the COVID-19 pandemic, from evaluating repurposed drugs in preventing severe disease to using sentinel surveillance to monitor SARS-CoV-2 transmission rates and studying the prevalence of “long COVID” in pediatric patients.
-
Study Identifies Mechanisms Promoting Bacterial Survival
Northwestern Medicine investigators have uncovered novel regulatory mechanisms that promote bacterial survival, according to findings published in PNAS.
-
Targeting Ion Channels to Manage Osteoarthritis Pain
Therapeutically targeting ion channels in nociceptor neurons may be a promising strategy for managing osteoarthritis pain, according to a Northwestern Medicine study.
-
Widespread Bias, Discrimination Directed Toward People With Disabilities Who Seek Healthcare
A new study shows physicians may be choosing to deny care to people with disabilities, and some use discretionary excuses to strategically discharge them from their practice.
-
Celebrating the Future of Medical Education
Faculty, staff and students shared presentations, workshops and discussions on the future of medical education at Feinberg’s 12th annual Medical Education Day, held September 30.
